2-44201669-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002706.6(PPM1B):āc.470A>Gā(p.Tyr157Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00019 in 1,614,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002706.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPM1B | NM_002706.6 | c.470A>G | p.Tyr157Cys | missense_variant | 2/6 | ENST00000282412.9 | NP_002697.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PPM1B | ENST00000282412.9 | c.470A>G | p.Tyr157Cys | missense_variant | 2/6 | 1 | NM_002706.6 | ENSP00000282412.4 | ||
ENSG00000285542 | ENST00000649044.1 | n.470A>G | non_coding_transcript_exon_variant | 2/15 | ENSP00000497083.1 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152188Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000382 AC: 96AN: 251274Hom.: 0 AF XY: 0.000302 AC XY: 41AN XY: 135778
GnomAD4 exome AF: 0.000185 AC: 270AN: 1461882Hom.: 0 Cov.: 31 AF XY: 0.000188 AC XY: 137AN XY: 727240
GnomAD4 genome AF: 0.000237 AC: 36AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74354
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 21, 2021 | The c.470A>G (p.Y157C) alteration is located in exon 2 (coding exon 1) of the PPM1B gene. This alteration results from a A to G substitution at nucleotide position 470, causing the tyrosine (Y) at amino acid position 157 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at